Nicorette (nicotine polacrilex)
Company: SmithKline Beecham
Approval Status: Approved February 1996
Treatment for: smoking cessation
Areas: Psychiatry/Psychology
General Information
Nicorette has been approved as an over-the-counter (OTC) aid in smoking cessation. The OTC nicotine gum product will be available in the same dosage strengths as the prescription product.
Nicorette relieves withdrawal symptoms by providing a temporary alternative source of nicotine, thereby easing the transition for an individual committed to smoking cessation. The nicotine in Nicorette reaches the bloodstream more gradually and at lower doses than delivered by cigarettes. While Nicorette controls withdrawal symptoms, thus addressing the physical addiction of smoking, the individual works to control the social and psychological aspects of the smoking habit.
The OTC version of Nicorette will be available in prescription strengths of 2 mg and 4 mg.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
Medical Dictionary Searches
